Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.


Disease Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Muscle Injury, Skeletal/Smooth Muscle disorders Adult or Tissue Stem Cell Personalized cell therapy, Therapeutic Approach UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Cancer, Solid Tumors Adult or Tissue Stem Cell Personalized cell therapy, Therapeutic Approach BioEclipse Therapeutics INC.
Clinical Trial, Phase 1 or Phase 1/2
Heart Disease, Heart failure Embryonic Stem Cell Donor cell therapy, Therapeutic Approach Stanford
Clinical Trial, Phase 1 or Phase 1/2
B cell cancers, Blood Cancer, Cancer, Leukemia, Leukemia, Acute Myeloid (AML) Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Stanford
Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer, Cancer, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach Stanford
Clinical Trial, Phase 1 or Phase 1/2
Neurological Disorders, Stroke Embryonic Stem Cell Donor cell therapy, Therapeutic Approach Stanford
Clinical Trial, Phase 1 or Phase 1/2
Amyotrophic Lateral Sclerosis, Neurological Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer, Cancer, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach COH
Clinical Trial, Phase 1 or Phase 1/2
Neurological Disorders, Parkinson's Disease Vital Research Opportunity Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach Brain Neurotherapy Bio
Clinical Trial, Phase 1 or Phase 1/2
HIV/AIDS, Immune Disease, Infectious Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSF
Clinical Trial, Phase 1 or Phase 1/2
Corneal Damage, Vision Loss Adult or Tissue Stem Cell Personalized cell therapy, Therapeutic Approach UCLA
Clinical Trial, Phase 1 or Phase 1/2
Retinitis Pigmentosa, Vision Loss Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer, Breast Cancer, Cancer, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach COH
Clinical Trial, Phase 1 or Phase 1/2
Cystinosis, Kidney Disease, Kidney Failure, Metabolic Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSD
Clinical Trial, Phase 1 or Phase 1/2
Retinitis Pigmentosa, Vision Loss Therapeutic Approach jCyte
Clinical Trial, Phase 2
Diabetes, Metabolic Disorders, Type 1 diabetes Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach UCSF
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Severe Combined Immunodeficiency, X-linked (X-SCID) Adult or Tissue Stem Cell Antibody, Biologic, Therapeutic Approach Jasper Therapeutics, Inc.
Clinical Trial, Phase 1 or Phase 1/2
Kidney Disease, Kidney Failure Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Stanford
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Sickle Cell Disease Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach COH
Clinical Trial, Phase 1 or Phase 1/2
Cancer, Lung Cancer, Solid Tumors Adult or Tissue Stem Cell Antibody, Biologic, Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCLA
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSF
Clinical Trial, Phase 1 or Phase 1/2
Kidney Disease, Kidney Failure Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Medeor Therapeutics
Clinical Trial, Phase 3
Blood Cancer, Blood Disorders, Bone Marrow Transplant and Viral Infection, Cancer Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach CHLA
Clinical Trial, Phase 1 or Phase 1/2
Retinitis Pigmentosa, Vision Loss Other Donor cell therapy, Therapeutic Approach jCyte
Clinical Trial, Phase 2
Blood Disorders, Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID) Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach St. Jude
Clinical Trial, Phase 1 or Phase 1/2
Kidney Disease, Kidney Failure Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Stanford
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Genetic Disorder, Immune Disease, Pediatrics, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCLA
Clinical Trial, Phase 2
Alpha Thalassemia Major, Blood Disorders Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach UCSF
Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer, Cancer, HIV-related Lymphoma, HIV/AIDS, Infectious Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Immune Disease, Pediatrics, X-linked Chronic Granulomatous Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCLA
Clinical Trial, Phase 1 or Phase 1/2
Neurological Disorders, Spinal Cord Injury Embryonic Stem Cell Donor cell therapy, Therapeutic Approach UCSD
IND
UCLA
Blood Cancer, Cancer, Multiple Myeloma Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSF
IND
Cancer, Sarcoma, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach CHLA
IND
Developmental Disorders, Genetic Disorder, Neurological Disorders, Pediatrics Gene Therapy (All), Gene Therapy, cell free, Nucleic acid based therapy, Therapeutic Approach Elpida Therapeutics
IND
Heart Disease, Heart failure Adult or Tissue Stem Cell, Somatic Cell Biologic, Exosomes based therapy, Therapeutic Approach Cedars-Sinai
IND
Cancer, Ovarian Cancer, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach COH
IND
Blood Disorders, Bone Marrow Transplant and Viral Infection Somatic Cell Biologic, Gene modification, Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach Tr1X Inc.
Clinical Trial, Phase 1 or Phase 1/2
Bone or Cartilage Disease, Cartilage defect Somatic Cell Donor cell therapy, Therapeutic Approach UC Irvine
IND
Stanford
Blood Cancer, Cancer, Leukemia, Acute Myeloid (AML) Small molecule therapy, Therapeutic Approach Aspera Biomedicines, Inc.
IND
Neurological Disorders, Parkinson's Disease iPS Cell Donor cell therapy, Therapeutic Approach Kenai Therapeutics
IND
Age-related macular degeneration, Vision Loss iPS Cell Personalized cell therapy, Therapeutic Approach UCLA
IND
Genetic Disorder, Metabolic Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach Rampart Bioscience
IND
B cell cancers, Blood Cancer, Cancer, Solid Tumors Cancer Stem Cell Biologic, Protein/peptide therapy, Therapeutic Approach Nammi Therapeutics, Inc.
IND
Immune Disease Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Ossium Health, Inc.
IND
Breast Cancer, Cancer, Melanoma, Solid Tumors Somatic Cell Donor cell therapy, Therapeutic Approach Calidi Biotherapeutics, Inc.
IND
Neurological Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Personalized cell therapy, Therapeutic Approach UC Davis
IND
Genetic Disorder, Metabolic Disorders, Neurological Disorders, Pediatrics Somatic Cell Stanford
IND
Blood Disorders, X-linked Chronic Granulomatous Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach ImmunoVec
Clinical Trial, Phase 1 or Phase 1/2
1 2 3 4 5 6
Displaying 201 - 250 of 256